4896 — K Pharma Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for K Pharma, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -229 | -391 | 301 | -844 | -990 |
| Depreciation | |||||
| Non-Cash Items | 9.63 | 36.7 | 64.9 | 7.6 | 74.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 16.4 | -9.67 | 88.4 | -147 | -1.78 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -196 | -363 | 454 | -984 | -918 |
| Capital Expenditures | — | -30 | -9.8 | -14.5 | -11.2 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.25 | -2.78 | -1.3 | — | -43.5 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.25 | -32.7 | -11.1 | -14.5 | -54.7 |
| Financing Cash Flow Items | 0 | -0.09 | -10.1 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 368 | 1,544 | 1,486 | — | 1,496 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 172 | 1,148 | 1,930 | -998 | 524 |